Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Feb 15, 2022; 14(2): 434-449
Published online Feb 15, 2022. doi: 10.4251/wjgo.v14.i2.434
Published online Feb 15, 2022. doi: 10.4251/wjgo.v14.i2.434
Study | Period | Total of patient with initial unresectable gastric cancer | Number of conversion to surgery | Number of R0 resection |
Nakajima et al[35] | 1989-1995 | 30 | 19 | 9 (30%) |
Yamaguchi et al[79] | 2001-2013 | 259 | 84 | 43 (51%) |
Sato et al[80] | 2002-2014 | 100 | 33 | 28 (85%) |
Fukuchi et al[81] | 2003-2013 | 151 | 40 (26%) | 32 (80%) |
Nakamura et al[82] | 2005-2014 | 59 | 15 (%) | 12 (100%) |
Morgagni et al[37] | 2005-2016 | 73 | 22 | 22 (100%) |
Yasufuku et al[83] | 2009-2015 | 39 | 13 | 10 (77%) |
- Citation: Chevallay M, Wassmer CH, Iranmanesh P, Jung MK, Mönig SP. Multimodal treatment in oligometastatic gastric cancer. World J Gastrointest Oncol 2022; 14(2): 434-449
- URL: https://www.wjgnet.com/1948-5204/full/v14/i2/434.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i2.434